Dahl M - Search Results

1

Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.

Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Dahl M, et al. Am J Respir Crit Care Med. 2001 Sep 15;164(6):1008-11. doi: 10.1164/ajrccm.164.6.2010067. Am J Respir Crit Care Med. 2001. PMID: 11587987

2

Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.

Dahl M, Nordestgaard BG, Lange P, Vestbo J, Tybjaerg-Hansen A. Dahl M, et al. Clin Chem. 2001 Jan;47(1):56-62. Clin Chem. 2001. PMID: 11148177

3

Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.

Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A. Dahl M, et al. J Allergy Clin Immunol. 2001 May;107(5):818-23. doi: 10.1067/mai.2001.114117. J Allergy Clin Immunol. 2001. PMID: 11344348

4

EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.

Lee J, Nordestgaard BG, Dahl M. Lee J, et al. Among authors: dahl m. Eur Respir J. 2011 Jan;37(1):18-25. doi: 10.1183/09031936.00012110. Epub 2010 Jun 1. Eur Respir J. 2011. PMID: 20516053 Free article.

5

Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.

Bækvad-Hansen M, Nordestgaard BG, Dahl M. Bækvad-Hansen M, et al. Among authors: dahl m. Eur Respir J. 2011 Apr;37(4):791-9. doi: 10.1183/09031936.00026410. Epub 2010 Aug 6. Eur Respir J. 2011. PMID: 20693256 Free article.

6

Scavenger receptor AI/II truncation, lung function and COPD: a large population-based study.

Thomsen M, Nordestgaard BG, Tybjaerg-Hansen A, Dahl M. Thomsen M, et al. Among authors: dahl m. J Intern Med. 2011 Mar;269(3):340-8. doi: 10.1111/j.1365-2796.2010.02308.x. Epub 2010 Nov 16. J Intern Med. 2011. PMID: 21077973 Free article.

7

β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.

Thomsen M, Nordestgaard BG, Sethi AA, Tybjærg-Hansen A, Dahl M. Thomsen M, et al. Among authors: dahl m. Eur Respir J. 2012 Mar;39(3):558-66. doi: 10.1183/09031936.00023511. Epub 2011 Nov 10. Eur Respir J. 2012. PMID: 22075484 Free article.

8

Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study.

Benfield TL, Dahl M, Nordestgaard BG, Tybjaerg-Hansen A. Benfield TL, et al. Among authors: dahl m. J Infect Dis. 2005 Nov 15;192(10):1851-7. doi: 10.1086/497167. Epub 2005 Oct 12. J Infect Dis. 2005. PMID: 16235188

9

Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample.

Dahl M, Tybjaerg-Hansen A, Wittrup HH, Lange P, Nordestgaard BG. Dahl M, et al. Genomics. 1998 May 15;50(1):89-96. doi: 10.1006/geno.1998.5272. Genomics. 1998. PMID: 9628826

10

DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.

Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. Dahl M, et al. Lancet. 1998 Jun 27;351(9120):1911-3. doi: 10.1016/s0140-6736(97)11419-2. Lancet. 1998. PMID: 9654257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,126 results

Search Page

Filters